Proceedings of the Twentieth International Symposium on Blood Transfusion, Groningen 1995, organized by the Red Cross Blood Bank Noord-Nederland.
First Statement of Responsibility
C Th Smit Sibinga
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Boston
Name of Publisher, Distributor, etc.
Springer US
Date of Publication, Distribution, etc.
1996
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
(257 pages)
CONTENTS NOTE
Text of Note
TRIGGER FACTORS IN TRANSFUSION MEDICINE; DEVELOPMENTS IN HEMATOLOGY AND IMMUNOLOGY Volume 31; Editor's page; Copyright; Baxter Acknowledgement; CONTENTS; MODERATORS AND SPEAKERS; FOREWORD; I. DEMAND AND SUPPLY; CUSTOMER-ORIENTED QUALITY SYSTEMS IN TRANSFUSION MEDICINE; COMMUNICATION MECHANISMS BETWEEN THE BEDSIDE AND THE BLOOD BANK ; INFORMED CONSENT FOR TRANSFUSION RECIPIENTS: HOW MUCH IS ENOUGH?; FACTORS THAT INFLUENCE DEMAND FOR TRANSFUSION; THE PROCESS OF CLINICAL DECISION-MAKING IN TRANSFUSION MEDICINE: INCORPORATING GUIDELINES AND ALGORITHMS INTO TRANSFUSION PRACTICES; DISCUSSION. II. PRODUCT QUALITIES AND CHARACTERISTICSFACTORS DEFINING THE CLINICAL NEED FOR SUPPORTIVE HAEMOTHERAPY; FACTORS AFFECTING THE CLINICAL EFFICACY OF BLOOD TRANSFUSION; THE CLINICAL RELEVANCE AND BIOLOGICAL EFFECTS OF LEUKOCYTES PRESENT IN CELLULAR BLOOD COMPONENTS; PLATELETS: WHAT QUALITIES AND CHARACTERISTICS DO JUSTIFY THE NEED FOR TRANSFUSION?; CLINICAL RELEVANCE OF CLOTTING FACTOR CHARACTERISTICS; DISCUSSION; III. TRANSFUSION POLICIES AND CLINICAL PRACTICE; FACTS, FEARS AND FORMULAS ABOUT BLOOD TRANSFUSIONS: ON THE ASSESSMENT, ACCEPTANCE AND CONTROL OF RISKS. SURGICAL CRITERIA FOR BLOOD TRANSFUSION: HOW FAR SHOULD WE GO?TRANSFUSION POLICIES WO CLINICAL PRACTICE IN A TERTIARY ACADEMIC MEDICAL CENTER: ROLE OF PROTOCOLS AND DOCUMENTATION; CHOICE OF SINGLE DONOR AND RANDOM DONOR PLATELET TRANSFUSION --;ITS COSTS; ETHICAL ASPECTS OF THE TRANSFUSION OF BLOOD: RESTRICTIVE OR JUSTIFYING?; WHAT TRIGGERS THE INITIATIVE OF DEVELOPMENTS IN TRANSFUSION MEDICINE: ADVANCES IN EX VIVO HAEMATOPOIETIC CELL THERAPY AND NEXT GENERATION TRANSFUSION PRODUCTS.; DISCUSSION; IV. EVALUATION AND FEED-BACK OF TRANSFUSION POLICIES. EVALUATION OF BEDSIDE TRANSFUSION PRACTICE: BENEFITS VS RISKSTHE CLINICAL CONSULTATIVE ROLE OF THE BLOOD BANK IN TRANSFUSION MEDICINE; AUDITING IN TRANSFUSION MEDICINE: APPROACHES TO OPTIMIZING TRANSFUSION PRACTICE; LEGISLATIVE AND REGULATORY IMPACT ON TRANSFUSION MEDICINE PRACTICE; DISCUSSION; INDEX.